336
Views
4
CrossRef citations to date
0
Altmetric
Articles

Home Manufacture of Drugs: An Online Investigation and a Toxicological Reality Check of Online Discussions on Drug Chemistry

, M.Sc., , M.Sc., , Ph.D. & , Ph.D.
Pages 279-288 | Received 30 Jan 2017, Accepted 09 Mar 2017, Published online: 23 May 2017

References

  • Alves, E. A., J. P. Grund, C. M. Afonso, A. D. Netto, F. Carvalho, and R. J. Dinis-Oliveira. 2015a. The harmful chemistry behind krokodil (desomorphine) synthesis and mechanisms of toxicity. Forensic Science International 249:207–13. doi:10.1016/j.forsciint.2015.02.001.
  • Alves, E. A., J. X. Soares, C. M. Afonso, J. C. Grund, A. S. Agonia, S. M. Cravo, A. D. Netto, F. Carvalho, and R. J. Dinis-Oliveira. 2015b. The harmful chemistry behind “krokodil”: Street-like synthesis and product analysis. Forensic Science International 257:76–82. doi:10.1016/j.forsciint.2015.07.042.
  • Biesk, J. 2013. Two more patients seek treatment at Joliet Hospital after injecting flesh-eating “crocodile” drug. Chicago Sun Times. http://southtownstar.suntimes.com/23081405-522/two-more-patients-seek-treatment-at-joliet-hospital-after-injecting-flesh-eating-crocodile-drug.html ( accessed March 28, 2016).
  • Brennan, R., and M. C. Van Hout. 2014. Gamma-hydroxybutyrate (GHB): A scoping review of pharmacology, toxicology, motives for use, and user groups. Journal of Psychoactive Drugs 46 (3):243–51. doi:10.1080/02791072.2014.921746.
  • Brzeczko, A. W., R. Leech, and J. G. Stark. 2013. The advent of a new pseudoephedrine product to combat methamphetamine abuse. The American Journal of Drug and Alcohol Abuse 39 (5):284–90. doi:10.3109/00952990.2013.821476.
  • Caldicott, D. G. E., and C. Duff. 2005. Reducing drug-related harm: Australia leads the way. Medical Journal of Australia 182 (3):140.
  • Caldicott, D. G. E., P. E. Pigou, R. Beattie, and J. W. Edwards. 2005. Clandestine drug laboratories in Australia and the potential for harm. Australian and New Zealand Journal of Public Health 29 (2):155–62. doi:10.1111/j.1467-842X.2005.tb00066.x.
  • Chenail, R. J. 2011. Qualitative researchers in the blogosphere: Using blogs as diaries and data. Qualitative Report 16 (1):364–73.
  • Chintalova-Dallas, R., P. Case, N. Kitsenko, and Z. Lazzarini. 2009. Boltushka: A homemade amphetamine-type stimulant and HIV risk in Odessa, Ukraine. International Journal of Drug Policy 20 (4):347–51. doi:10.1016/j.drugpo.2008.09.003.
  • Csémy, L., L. Kubička, and A. Nociar. 2002. Drug scene in the Czech Republic and Slovakia during the period of transformation. European Addiction Research 8 (4):159–65. doi:10.1159/000066134.
  • Dalgarno, P., and D. Shewan. 2005. Reducing the risks of drug use: The case for set and setting. Addiction Research & Theory 13 (3):259–65. doi:10.1080/16066350500053562.
  • David, G. E., A. Coxon, R. D. Frew, and A. R. Hayman. 2010. Isotope fractionation during precipitation of methamphetamine HCl and discrimination of seized forensic samples. Forensic Science International 200 (1–3):123–29. doi:10.1016/j.forsciint.2010.03.043.
  • De-Carolis, C., G. A. Boyd, L. Mancinelli, S. Pagano, and S. Eramo. 2015. Methamphetamine abuse and “meth mouth” in Europe. Medicina Oral Patología Oral y Cirugia Bucal 20 (2):e205–10. doi:10.4317/medoral.20204.
  • Degenhardt, L., S. Darke, and P. Dillon. 2003. The prevalence and correlates of gamma-hydroxybutyrate (GHB) overdose among Australian users. Addiction 98 (2):199–204. doi:10.1046/j.1360-0443.2003.00265.x.
  • Deluca, P., Z. Davey, O. Corazza, L. Di Furia, M. Farre, L. H. Flesland, M. Mannonen, A. Majava, T. Peltoniemi, M. Pasinetti, C. Pezzolesi, N. Scherbaum, H. Siemann, A. Skutle, M. Torrens, P. Van der Kreeft, E. Iversen, and F. Schifano. 2012. Identifying emerging trends in recreational drug use: Outcomes from the Psychonaut Web Mapping Project. Progress in Neuro-Psychopharmacology & Biological Psychiatry 39 (2):221–26. doi:10.1016/j.pnpbp.2012.07.011.
  • Dinis-Oliveira, R. J., F. Carvalho, R. Moreira, J. A. Duarte, J. B. Proenca, A. Santos, and T. Magalhaes. 2012. Clinical and forensic signs related to opioids abuse. Current Drug Abuse Reviews 5 (4):273–90. doi:10.2174/1874473711205040003.
  • Dumchev, K. V., R. Soldyshev, H.-Z. Qian, O. O. Zezyulin, S. D. Chandler, P. Slobodyanyuk, L. Moroz, and J. E. Schumacher. 2009. HIV and hepatitis C virus infections among hanka injection drug users in central Ukraine: A cross-sectional survey. Harm Reduction Journal 6:23. doi:10.1186/1477-7517-6-23.
  • Friedman, S., W. De Jong, D. Rossi, G. Touzé, R. Rockwell, D. Des Jarlais, and R. Elovich. 2007. Harm reduction theory: Users’ culture, micro-social indigenous harm reduction, and the self-organization and outside-organizing of users’ groups. International Journal of Drug Policy 18:107–17. doi:10.1016/j.drugpo.2006.11.006.
  • Grund, J. C. 2002. A candle lit from both sides. In HIV and AIDS: A global view, ed. K. McElrath. Westport, CT: Greenwood Press.
  • Grund, J. C. 2005. The eye of the needle. In Injecting illicit drugs, ed. R. Pates, A. McBride, and K. Arnold, 11–32. London, UK: Blackwell.
  • Grund, J. P., P. Coffin, M. Jauffret-Routside, M. Dijkstra, D. De Bruin, and P. Blanken. 2010. The fast and furious: Cocaine, amphetamines and harm reduction. In Harm reduction: Evidence, impacts and challenges, ed. T. Rhodes and D. Hedrich, 191–232. Luxembourg: EMCDDA.
  • Grund, J. P., S. R. Friedman, L. S. Stern, B. Jose, A. Neaigus, R. Curtis, and D. C. Des Jarlais. 1996. Syringe-mediated drug sharing among injecting drug users: Patterns, social context and implications for transmission of blood-borne pathogens. Social Science & Medicine 42 (5):691–703. doi:10.1016/0277-9536(95)00193-X.
  • Grund, J. P., C. D. Kaplan, N. F. Adriaans, and P. Blanken. 1991. Drug sharing and HIV transmission risks: The practice of frontloading in the Dutch injecting drug user population. Journal of Psychoactive Drugs 23 (1):1–10. doi:10.1080/02791072.1991.10472569.
  • Grund, J. P., A. Latypov, and M. Harris. 2013. Breaking worse: The emergence of krokodil and excessive injuries among people who inject drugs in Eurasia. International Journal of Drug Policy 24 (4):265–74. doi:10.1016/j.drugpo.2013.04.007.
  • Grund, J. P., T. Zabransky, K. S. Irwin, and R. Heimer. 2009. Stimulant use in Central and Eastern Europe: How recent social history shaped current drug consumption patterns. In Interventions for amphetamine misuse, ed. R. Pates and D. Riley, 173–203. Oxford, UK: Wiley-Blackwell.
  • Hagan, H., H. Thiede, N. S. Weiss, S. G. Hopkins, J. S. Duchin, and E. R. Alexander. 2001. Sharing of drug preparation equipment as a risk factor for Hepatitis C. American Journal of Public Health 91 (1):42–46. doi:10.2105/AJPH.91.1.42.
  • Harris, M. 2013. The “do-it-yourself” New Zealand injecting scene: Implications for harm reduction. International Journal of Drug Policy 24(4):281–83. doi:10.1016/j.drugpo.2012.06.007.
  • Heimer, R. 2013. Patterns of new drug emergence: A comment in light of “krokodil.” International Journal of Drug Policy 24 (4):275–77. doi:10.1016/j.drugpo.2013.06.003.
  • Husserl, E. 1970. Logical investigation. New York, NY: Humanities Press.
  • Jose, B., S. R. Friedman, A. Neaigus, R. Curtis, J. P. Grund, M. F. Goldstein, T. P. Ward, and D. C. Des Jarlais. 1993. Syringe-mediated drug-sharing (backloading): A new risk factor for HIV among injecting drug users. AIDS 7 (12):1653–60. doi:10.1097/00002030-199312000-00017.
  • Katselou, M., I. Papoutsis, P. Nikolaou, C. Spiliopoulou, and S. Athanaselis. 2014. A “krokodil” emerges from the murky waters of addiction: Abuse trends of an old drug. Life Sciences 102 (2):81–87. doi:10.1016/j.lfs.2014.03.008.
  • Kjellgren, A., H. Henningsson, and C. Soussan. 2013. Fascination and social togetherness: Discussions about spice smoking on a Swedish Internet forum. Substance Abuse 7:191–98.
  • Kjellgren, A., and K. Jonsson. 2013. Methoxetamine (MXE): A phenomenological study of experiences induced by a “legal high” from the Internet. Journal of Psychoactive Drugs 45 (3):276–86. doi:10.1080/02791072.2013.803647.
  • Kohrs, F. P., C. Mann, and R. Greenberg. 2004. The use of amphetamine in gamma-hydroxybutyrate overdose: A case report. Journal of Psychoactive Drugs 36 (3):401–02. doi:10.1080/02791072.2004.10400040.
  • Kozinets, R. V. 2002. The field behind the screen: Using netnography for marketing research in online communities. Journal of Marketing Research 39 (1):61–62.
  • Kunalan, V., W. J. Kerr, and N. N. Daeid. 2012. Investigation of the reaction impurities associated with methylamphetamine synthesized using the Nagai method. Analytical Chemistry 84 (13):5744–52. doi:10.1021/ac3009302.
  • Li, J., S. A. Stokes, and A. Woeckener. 1998. A tale of novel intoxication: A review of the effects of γ-hydroxybutyric acid with recommendations for management. Annals of Emergency Medicine 31 (6):729–36. doi:10.1016/S0196-0644(98)70232-X.
  • Maxwell, J. C., and B. A. Rutkowski. 2008. The prevalence of methamphetamine and amphetamine abuse in North America: A review of the indicators, 1992–2007. Drug & Alcohol Review 27 (3):229–35. doi:10.1080/09595230801919460.
  • McKetin, R., N. Kozel, J. Douglas, R. Ali, B. Vicknasingam, J. Lund, and J.-H. Li. 2008. The rise of methamphetamine in Southeast and East Asia. Drug & Alcohol Review 27 (3):220–28. doi:10.1080/09595230801923710.
  • Miovsky, M. 2007. Changing patterns of drug use in the Czech Republic during the post-communist era: A qualitative study. Journal of Drug Issues 37 (1):73–102. doi:10.1177/002204260703700104.
  • Miovský, M., P. M. Miller, J. P. Grund, V. Beláčková, R. Gabrhelík, and J. Libra. 2015. Academic education in addictology (addiction science) in the Czech Republic: Analysis of the (pre-1989) historical origins. Nordic Studies on Alcohol and Drugs 32 (5):527–38. doi:10.1515/nsad-2015-0050.
  • Móró, L., and J. Rácz. 2013. Online drug user-led harm reduction in Hungary: A review of “Daath.” Harm Reduction Journal 10:18. doi:10.1186/1477-7517-10-18.
  • Mueller, S. R., A. Y. Walley, S. L. Calcaterra, J. M. Glanz, and I. A. Binswanger. 2015. A review of opioid overdose prevention and naloxone prescribing: Implications for translating community programming into clinical practice. Substance Abuse 36 (2):240–53. doi:10.1080/08897077.2015.1010032.
  • Nikolaou, P., S. Athanaselis, I. Papoutsis, A. Dona, C. Spiliopoulou, and M. Stefanidou. 2014. Emergency issues of clandestine production of drugs: The case of “Sisha”: The homemade crystal meth in Greece. Journal of Forensic Toxicology and Pharmacology 3 (2).
  • Rhodes, T. 2002. The “risk environment”: A framework for understanding and reducing drug-related harm. International Journal of Drug Policy 13 (2):85–94.
  • Rhodes, T. 2009. Risk environments and drug harms: A social science for harm reduction approach. International Journal of Drug Policy 20 (3):193–201. doi:10.1016/j.drugpo.2008.10.003.
  • Rhodes, T., C. Lowndes, A. Judd, L. A. Mikhailova, A. Sarang, A. Rylkov, M. Tichonov, K. Lewis, N. Ulyanova, T. Alpatova, V. Karavashkin, M. Khutorskoy, M. Hickman, J. V. Parry, and A. Renton. 2002. Explosive spread and high prevalence of HIV infection among injecting drug users in Togliatti City, Russia. AIDS 16 (13):F25–F31. doi:10.1097/00002030-200209060-00002.
  • Soussan, C., and A. Kjellgren. 2014. Harm reduction and knowledge exchange: A qualitative analysis of drug-related Internet discussion forums. Harm Reduction Journal 11:25. doi:10.1186/1477-7517-11-25.
  • Soussan, C., and A. Kjellgren. 2015. “Chasing the high”—Experiences of ethylphenidate as described on international internet forums. Substance Abuse: Research and Treatment 9:9–16.
  • UNODC. 2013. World drug report. New York, NY: United Nations Publications.
  • UNODC. 2014. Global synthetic drugs assessment: Amphetamine-type stimulants and new psychoactive substances. New York, NY: United Nations.
  • Van Amsterdam, J., T. Brunt, E. Pennings, and W. Van den Brink. 2014. Risk assessment of GBL as a substitute for the illicit drug GHB in the Netherlands: A comparison of the risks of GBL versus GHB. Regulatory Toxicology and Pharmacology 70 (2):507–13. doi:10.1016/j.yrtph.2014.08.014.
  • Van Gaalen, S., D. De Bruin, and J. P. C. Grund. 2015. GHB overdose prevention among people who use GHB at home in the Netherlands and Belgium (2014–2015): An exploration of the characteristics associated with overdose and opportunities for risk reduction. Amsterdam, the Netherlands: Mainline Foundation Amsterdam.
  • Van Hout, M. C. 2014. Kitchen chemistry: A scoping review of the diversionary use of pharmaceuticals for non-medicinal use and home production of drug solutions. Drug Testing & Analysis 6 (7–8):778–87. doi:10.1002/dta.1622.
  • Van Hout, M. C. 2015. “Nod and wave”: An Internet study of the codeine intoxication phenomenon. International Journal of Drug Policy 26 (1):67–77. doi:10.1016/j.drugpo.2014.06.016.
  • Van Hout, M. C., and E. Hearne. 2014. “Confessions of contemporary English opium-eaters”: A netnographic study of consumer negotiation of over the counter morphine for misuse. Journal of Substance Use 21 (2):141–52. doi:10.3109/14659891.2014.980861.
  • Van Hout, M. C., and E. Hearne. 2015a. “Plant or poison”: A netnographic study of recreational use of 1,3-dimethylamylamine (DMAA). International Journal of Drug Policy 26 (12):1279–81. doi:10.1016/j.drugpo.2015.04.002.
  • Van Hout, M. C., and E. Hearne. 2015b. “Vintage meds”: A netnographic study of user decision-making, home preparation, and consumptive patterns of laudanum. Substance Use & Misuse 50 (5):598–608. doi:10.3109/10826084.2014.991408.
  • Van Hout, M. C., and E. Hearne. 2015c. “Word of mouse”: indigenous harm reduction and online consumerism of the synthetic compound methoxphenidine. Journal of Psychoactive Drugs 47 (1):30–41. doi:10.1080/02791072.2014.974002.
  • Wertz, F. J. 2005. Phenomenological research methods for counseling psychology. Journal of Counseling Psychology 52 (2):167–77. doi:10.1037/0022-0167.52.2.167.
  • Wilkinson, D., and M. Thelwall. 2011. Researching personal information on the public web: Methods and ethics. Social Science Computer Review 29 (4):387–401. doi:10.1177/0894439310378979.
  • Zabransky, T. 2007. Methamphetamine in the Czech Republic. Journal of Drug Issues 37 (1):155–80. doi:10.1177/002204260703700108.
  • Zabransky, T., J. P. Grund, A. Latypov, D. Otiashvili, R. Stuikyte, O. Scutelniciuc, and P. Smyrnov. 2012a. Harm reduction in central and eastern Europe. In Harm reduction in substance use and high-risk behaviour, ed. R. Pates and D. Riley, 301–21. Oxford, UK: Wiley-Blackwell.
  • Zabransky, T., A. Latypov, I. Varentsov, D. Otiashvili, and J. P. Grund. 2012b. Harm reduction in Russia, south west and central Asia. In Harm reduction in substance use and high-risk behaviour, ed. D. R. R. Pates. Oxford, UK: Wiley-Blackwell.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.